
|Articles|August 1, 2017
- Pharmaceutical Executive-08-01-2017
- Volume 37
- Issue 8
Pharmaceutical Executive, August 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Health Policy Problem Solver: Fumie Griegoover 8 years ago
Dealmaking in 2017: Striking a Balanceover 8 years ago
Beyond the Science: Commercial Implications From ASCO 2017over 8 years ago
News Spotlight: Pharmaover 8 years ago
Pharma’s Marijuana Makeoverover 8 years ago
The 'Hear' and Now for Pharma and Social Mediaover 8 years ago
Pressure Mounts on FDA, Pharma to Tackle Opioid Abuseover 8 years ago
Syncing Social Media With Value-Care Modelover 8 years ago
AI-based Social Listening as Aid to Pharmacovigilanceover 8 years ago
Country Report: IndonesiaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
BioMarin Reaches $4.8 Billion Definitive Agreement to Acquire Amicus Therapeutics
2
President Trump Announces Nine More TrumpRx Participants
3
Senate Passes Biosecure Act
4
Eli Lilly Announces Topline Results From Phase III Trial Studying Oral GLP-1 Therapy Orforglipron
5



